TL Genomics Investors
TL Genomics is a developer of a prenatal diagnosis technology created to isolate fetal nucleated red blood cells in maternal blood.
Connections
Industry:
Deep Diagnostics
Investor Type:
Healthcare Company
Founded Date:
2015
Headquarters:
Koganei, Tokyo, Japan
Employee Number:
11-50